Patents Assigned to Bioalternatives
  • Patent number: 10080779
    Abstract: The invention disclosed herein relates to the field of epidermal repair and skin innate immunity. More particularly, the invention concerns the use of a mix of cytokines to inhibit keratinocyte differentiation, activate skin innate immunity, increase the expression of anti-microbial peptides, and improve epidermal repair. In particular, the invention concerns compositions comprising at least IL-17, TNF? and OSM that can be formulated for topical administration for cosmetic or dermatologic use.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: September 25, 2018
    Assignees: Universite D'Angers, Universite de Poitiers, Bioalternatives SAS
    Inventors: Jean-Claude Lecron, Hughes Gascan, Franck Morel, Sylvie Chevalier, Francois-Xavier Bernard, Katia Boniface, Caroline Diveau
  • Patent number: 8569358
    Abstract: Describe is a method of administering to a subject silymarin, or of the main constituents thereof alone or as a mixture, chosen from silybin (or 2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3, 5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxine), isosilybin, silydianin, silychristin, silandrin, silymonin and taxifolin, isolated enantiomers thereof and also salts thereof.
    Type: Grant
    Filed: February 13, 2006
    Date of Patent: October 29, 2013
    Assignees: GreenPharma, BioAlternatives
    Inventors: Philippe Bernard, Francois-Xavier Bernard
  • Patent number: 7901669
    Abstract: The present invention relates to the field of epidermal repair. More particularly, the invention concerns the use of a molecule able to activate a heteromeric receptor comprising OSMR? as a subunit, for the preparation of a composition for activating in vitro and/or in vivo keratinocyte migration and/or the expression of anti-microbial peptides by the keratinocytes. In particular, the invention concerns the use of OSM and/or IL-17 and/or TNF? and/or IL-31, or agonists thereof, for the preparation of cosmetic or dermatologic compositions.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: March 8, 2011
    Assignees: Universite d'Angers, Universite de Poitiers, Bioalternatives SAS
    Inventors: Jean-Claude Lecron, Hughes Gascan, Franck Morel, Sylvie Chevalier, François-Xavier Bernard, Katia Boniface, Caroline Diveu
  • Publication number: 20080033037
    Abstract: The present invention relates to the use of silymarin, or of the main constituents thereof alone or as a mixture, chosen from silybin (or 2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3,5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxine), isosilybin, silydianin, silychristin, silandrin, silymonin and taxifolin, isolated enantiomers thereof and also salts thereof, for the manufacture of compositions for inducing, restoring or stimulating pigmentation of the skin, body hair or head hair. The invention also relates to the use of these agents for the manufacture of compositions for preserving the integrity of the hair, for limiting its loss and for stimulating hair regrowth. Silymarin or the constituents thereof alone or as a mixture are obtained by extraction of a plant of the genus Silybum.
    Type: Application
    Filed: February 13, 2006
    Publication date: February 7, 2008
    Applicants: Greenpharma, Bioalternatives
    Inventors: Philippe Bernard, Francois-Xavier Bernard